Based on the results for Q1/2020, the company’s cash flow was as follows: - Net cash flow from operating activities was 56.5 MB, increased by 9.7 MB when compare with Q1/2019, the effective due to the

held on May 13, 2020, has passed the important resolutions which can be summarized as follows: 1. Approved the payment of the interim dividend from the operating results for the six months period ended

following details; Analysis of operating results (1) Revenue Year 2019, company and its subsidiaries has total revenue of 372.95 Million Baht as 38.38 Million Baht increased or 11.47 percent when compared to

. Please be informed accordingly. Yours Sincerely, (Mr. Chih-Hung Lin) Chief Operating Officer Company Secretary Office Telephone: 0 2658 8881

. The increase in shareholders’ equity was thanks to the booking of operating profit. Yours sincerely (Mr. Teerawat Srinakarin) Chief Executive Officer

due to expiring tax benefits. Profit EBITDA in FY22 was at Bt89,731mn, decreasing by -1.8%YoY from lower operating profit as an impact from normalized marketing expenses and high utility cost. EBITDA

investment solicitation and contact the Investment Scam Hotline if they have suspicious cases to report regarding persons, products or companies allegedly operating without license. The SEC will verify and

Q1 2018 THB mm THB mm Net cash generated (used in) from operating activities (475.7) (333.3) Net cash generated (used in) from investing activities 1,853.0 2,056.0 Net cash generated (used in) from

the Consolidated Financial Statements ended 31 December 2018, which have been audited by the Company’s authorized auditor. The Company would like to clarify the operating results of the Company and its

medical service concerning health and esthetics. 2. Overview of operating results in 3 quarters of 2019. Continued from the first Quarter of 2019 until third Quarter, the world economic still be tense from